Barclays
ALXA

Barclays’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Barclays’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100
Closed – – 6922
2016
Q1 		$0 Hold
100
– – ﹤0.01% 6735
2015
Q4 		$0 Sell
100
-2,500
-96% -$2.58K ﹤0.01% 7107
2015
Q3 		$3K Buy
+2,600
New +$3.04K ﹤0.01% 6282

Barclays's ALXA Position: Q2 2016 in Review

Barclays sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 100 shares.

Barclays first reported a position in ALXA in Q3 2015 and held it in 3 quarters. The position peaked at $3K in Q3 2015. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

  • Barclays reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Barclays sold 100 Alexza Pharmaceuticals Inc shares in Q2 2016.
  • Barclays first reported a position in Alexza Pharmaceuticals Inc in Q3 2015 and held it in 3 quarters.
  • Barclays's Alexza Pharmaceuticals Inc position peaked at $3K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.